Clinical Commissioning Policy: Stereotactic ablative radiotherapy (SABR) for Hepatocellular Carcinoma (adults)

Stereotactic ablative radiotherapy (SABR) will be available as a treatment option through routine commissioning for hepatocellular carcinoma in adults in accordance with criteria outlined within the commissioning policy.

NHS England